Shareholders have struggled to enforce corporate director accountability. Beyond contested board elections, shareholders today have little practical, direct impact on directors.
On one important subject, director pay, at almost all U.S. companies, directors have absolute authority over their compensation.
Read more
Companies increasingly are incorporating climate-related metrics into CEO pay packages. The effectiveness of CEO compensation as an accountability mechanism, however, hinges on at least three key factors.
Read more
In the last few years, companies have begun to use non-financial metrics more often in CEO pay packages. In 2021, 52 percent of S&P 500 companies reported including ESG metrics in compensation while 69 percent said they will be included in 2022 compensation packages.than one-third, posing the significant challenge of decoupling emissions from the sector’s growth.
Read more
Shareholder resolutions requesting companies disclose plans to achieve net zero emissions by 2050 received increased support in the 2021 proxy season. While this is a positive development, companies must do more to cut emissions in half by 2030 to meet the Paris climate treaty goals. The way to make this work is to have a direct link to executive compensation packages. If the board sets a real financial incentive then executives will make it happen.
Read more
Prescription drug expenditures make up nearly 20 percent of all health care costs, and spending for prescription drugs is growing faster than any other part of the health care dollar. A Kaiser Health Tracking Poll in early 2018 found that one out of four patients have a difficult time affording their medicines. December 2018 POLITICO poll showed the public’s top priority for the 116th Congress is taking action to lower prescription drug prices.
Read more